1-12 of 12
Saulius K. Girnius
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In -Class Transition ( i CT) from Parenteral Bortezomib (V) to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Community-Based US MM-6 Study: Subanalysis of Randomized Controlled Trial (RCT)-Ineligible and RCT-Eligible Pts

Saulius K. Girnius, Joshua Richter, Kimberly Bogard, Habte A. Yimer, Sudhir Manda, Roger M. Lyons, Stephen J. Noga, Robert M. Rifkin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6677.
https://doi.org/10.1182/blood-2023-179795
Published: 2023
Journal Articles

In -Class Transition ( i CT) from Parenteral Bortezomib to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients from the Community-Based US MM-6 Study: Subgroup Analyses of the Fully Accrued Dataset in Patients Aged <75 and ≥75 Years

Ruemu E. Birhiray, Robert M. Rifkin, Christopher A. Yasenchak, January Fields-Meehan, Roger M. Lyons, Ramalingham Ratnasabapathy, Kimberly Bogard, Kim Tran, Dasha Cherepanov, Stephen J. Noga, Saulius K. Girnius, Stephen J. Noga
Journal: Blood
Blood (2022) 140 (Supplement 1): 7322–7323.
https://doi.org/10.1182/blood-2022-163071
Published: 2022
Journal Articles

Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In -Class Transition ( i CT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation

Robert M. Rifkin, Stephen J. Noga, Saulius K. Girnius, Kimberly Bogard, Sudhir Manda, Habte Yimer, Presley Whidden, Ruemu E. Birhiray, Philip Twumasi-Ankrah, Yikun Guo, Rami Owera, Leon Bernal-Mizrachi, Roger Lyons
Journal: Blood
Blood (2021) 138 (Supplement 1): 2726.
https://doi.org/10.1182/blood-2021-150094
Published: 2021
Journal Articles

Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma

Sagar Lonial, Stefano R. Tarantolo, Ralph V. Boccia, Habte Yimer, Moshe Y. Levy, Rafat Abonour, Meera Mohan, Vivek Roy, Jeremy T. Larsen, Saulius K. Girnius, Cara A. Rosenbaum, Omar Nadeem, Deborah Berg, Bo Chao, Allison J Berger, Akito Nakamura, Yuhong Zhang, Keli Song, Christine K. Ward, Igor Proscurshim, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2742.
https://doi.org/10.1182/blood-2021-148385
Published: 2021
Journal Articles

In -Class Transition ( i CT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy Increases the Feasibility of Long-Term PI Treatment and Benefit for Newly Diagnosed Multiple Myeloma (NDMM) Patients in an Outpatient Setting: Updated Real-World Results from the Community-Based United States (US) MM-6 Study

Saulius K. Girnius, MD, Habte A. Yimer, MD, Stephen J. Noga, MDPhD, Sudhir Manda, MD, Roger M. Lyons, MD, Kimberly Bogard, PharmD, Presley Whidden, Dasha Cherepanov, Vickie Lu, PhD, Jack Aiello, EE, MS, BS, Joshua R. Richter, MD, Robert M. Rifkin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
https://doi.org/10.1182/blood-2020-140482
Published: 2020
Journal Articles

Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazomib-Based Induction: Results from the US MM-6 Study in the Real World (RW) Setting

Robert M. Rifkin, MD, Sudhir Manda, MD, Stephen J Noga, MD PhD, Habte A Yimer, MD, Saulius K. Girnius, MD, Ruemu Ejedafeta Birhiray, MD, Christopher A. Yasenchak, MD, Roger M. Lyons, MD, Presley Whidden, Robert L. Schlossman, MD, Bingxia Wang, PhD, Ralph V. Boccia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1882.
https://doi.org/10.1182/blood-2019-124747
Published: 2019
Journal Articles

Genomic Landscape of Sex Disparities in Multiple Myeloma

Susan Bal, MDMBBS, Kwangmin Choi, PhD, Omer Jamy, MD, Saulius K. Girnius, MD, Heather J Landau, MD, Luciano J. Costa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3067.
https://doi.org/10.1182/blood-2019-127429
Published: 2019
Journal Articles

Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation

Sagar Patel, MD, Saulius K. Girnius, MD, Binod Dhakal, MBBS, Lohith Gowda, MD, Raphael Fraser, PhD, Omar Davila, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Shaji K. Kumar, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 266.
https://doi.org/10.1182/blood-2019-127049
Published: 2019
Journal Articles

Genomic Landscape of Multiple Myeloma with Elevated Lactate Dehydrogenase

Susan Bal, MBBS, Saulius K. Girnius, MD, Daniel T. Starczynowski, PhD, Heather J. Landau, MD, Kwangmin Choi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 470.
https://doi.org/10.1182/blood-2018-99-115523
Published: 2018
Journal Articles

Clinical Outcomes of Newly Diagnosed Multiple Myeloma Patients with Elevated Lactate Dehydrogenase Who Underwent Autologous Hematopoietic Stem Cell Transplantation

Susan Bal, MBBS, Kwangmin Choi, PhD, Heather J. Landau, MD, Daniel T. Starczynowski, PhD, Saulius K. Girnius, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4623.
https://doi.org/10.1182/blood-2018-99-120077
Published: 2018
Journal Articles

Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients: The Insight-MM Study

Robert M Rifkin, Faith E Davies, MD, Antonio Palumbo, MD, Jeffrey Zonder, MD, Saulius K Girnius, MD, Caitlin L Costello, MD, Saad Z Usmani, MD FACP, Jesus G. Berdeja, MD, Jim Omel, Michael A Thompson, MD PhD, Jatin Shah, MD, J Sanford Schwartz, Roman Hajek, MD, Evangelos Terpos, MD PhD, Vânia Hungria, MD PhD, Maria-Victoria Mateos, MD PhD, Gordon Cook, Xavier Leleu, Andrew Spencer, Hartmut Goldschmidt, MD, Brian Seal, RPh, MBA, PhD, Chris L Pashos, PhD, Dawn Marie Stull, PharmD, FRACP, Dorothy Romanus, RPh, MSc, PhD, Roxanne Cacioppo, Jill A Bell, PhD, Shawn Yu, Katarina Luptakova, Liviu Niculescu, MD PhD, Stephen J Noga, Tomas Skacel, Ajai Chari, MD
Journal: Blood
Blood (2016) 128 (22): 5681.
https://doi.org/10.1182/blood.V128.22.5681.5681
Published: 2016
Journal Articles

Practice Patterns in Newly Diagnosed Multiple Myeloma in the Prospective Observational Commpass Trial

Joshua Necamp, MD, Sulsal Haque, MD, Saulius K Girnius, MD
Journal: Blood
Blood (2016) 128 (22): 4502.
https://doi.org/10.1182/blood.V128.22.4502.4502
Published: 2016